UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (16), p.7473-7478

2010

Volltextzugriff (PDF)

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Blood, 2008-08, Vol.112 (4), p.990-998

2008

Volltextzugriff (PDF)

Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3884-3891

2007

Volltextzugriff (PDF)

Young Adults with Multiple Myeloma

Seminars in oncology nursing, 2017-08, Vol.33 (3), p.316-331

2017

Volltextzugriff (PDF)

First Interim Results of a Phase I/II Study of Lenalidomide in Combination with Anti-PD-1 Monoclonal Antibody MDV9300 (CT-011) in Patients with Relapsed/Refractory Multiple Myeloma

Blood, 2015-12, Vol.126 (23), p.1838-1838

2015

Volltextzugriff (PDF)

The ASCO Study of Collaborative Practice Arrangements: A Nurse Practitioner's Point of View

Journal of the advanced practitioner in oncology, 2012-01, Vol.3 (1), p.47-48

Devine, Hollie

2012

Volltextzugriff (PDF)

Imatinib Mesylate-Induced Complete Cytogenetic Response in Acute Myeloid Leukemia with t(5;12)(q33;p13)

Blood, 2006-11, Vol.108 (11), p.4414-4414

2006

Volltextzugriff (PDF)

Mobilization of hematopoietic stem cells for use in autologous transplantation

Clinical journal of oncology nursing, 2010-04, Vol.14 (2), p.212

2010

Volltextzugriff (PDF)

Hematopoietic cell transplantation in the treatment of leukemia

Seminars in oncology nursing, 2003-05, Vol.19 (2), p.118-132

2003

Volltextzugriff (PDF)

Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine

American journal of hematology, 2006-07, Vol.81 (7), p.543-545

2006

Volltextzugriff (PDF)

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)

Blood, 2008-11, Vol.112 (11), p.2957-2957

2008

Volltextzugriff (PDF)

Hematopoietic cell transplantation in the treatment of leukemia: Advances in the diagnosis and treatment of adult leukemia

Seminars in oncology nursing, 2003, Vol.19 (2), p.118-132

2003

Volltextzugriff (PDF)

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Commentary

Blood, 2008, Vol.112 (4)

2008

Volltextzugriff (PDF)

Monoclonal Antibodies in the Treatment of Multiple Myeloma

Journal of the advanced practitioner in oncology, 2016-03, Vol.7 (2)

2016

Volltextzugriff (PDF)

New Agents in the Treatment of Multiple Myeloma

Journal of the advanced practitioner in oncology, 2016-03, Vol.7 (2)

2016

Volltextzugriff (PDF)

Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells

Investigative ophthalmology & visual science, 2010-12, Vol.51 (12), p.6815-6825

2010

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(7)
Science & Technology
(7)
Life Sciences & Biomedicine
(6)
Adult
(4)
Aged
(4)
Biological And Medical Sciences
(4)
Hematologic And Hematopoietic Diseases
(4)
Medical Sciences
(4)
Azacitidine - Analogs & Derivatives
(3)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(3)
Male
(3)
Middle Aged
(3)
Nursing
(3)
Oncology
(3)
Remission Induction
(3)
Aged, 80 And Over
(2)
Azacitidine - Administration & Dosage
(2)
Blood
(2)
Decitabine
(2)
Female
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia

Young Adults with Multiple Myeloma

First Interim Results of a Phase I/II Study of Lenalidomide in Combination with Anti-PD-1 Monoclonal Antibody MDV9300 (CT-011) in Patients with Relapsed/Refractory Multiple Myeloma

The ASCO Study of Collaborative Practice Arrangements: A Nurse Practitioner's Point of View

Imatinib Mesylate-Induced Complete Cytogenetic Response in Acute Myeloid Leukemia with t(5;12)(q33;p13)

Mobilization of hematopoietic stem cells for use in autologous transplantation

Hematopoietic cell transplantation in the treatment of leukemia

Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)

Hematopoietic cell transplantation in the treatment of leukemia: Advances in the diagnosis and treatment of adult leukemia

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Commentary

Monoclonal Antibodies in the Treatment of Multiple Myeloma

New Agents in the Treatment of Multiple Myeloma

Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells

Suchergebnisse filtern